Estimates of the lifetime prevalence of posttraumatic stress disorder (PTSD) in American adults range from 6.4% to 6.8%. PTSD is associated with increased risk for comorbid major depression, substance use disorder, suicide, and a variety of other mental and physical health conditions. Given the negative sequelae of trauma/PTSD, research has focused on identifying efficacious interventions that could be administered soon after a traumatic event to prevent or reduce the subsequent incidence of PTSD. While early psychosocial interventions have been shown to be relatively ineffective, early (secondary) pharmacological interventions have shown promise. These pharmacological approaches are largely based on the hypothesis that disruption of altered stress hormone levels and the consequent formation of trauma memories could protect against the development of PTSD. The present manuscript reviews the literature regarding the role of peri-traumatic stress hormones as risk factors for the development of PTSD and reviews evidence for the efficacy of exogenously modulating stress hormone levels to prevent/buffer the development of PTSD symptoms. Whereas prior literature has focused primarily on either child or adult studies, the present review incorporates both child and adult studies in a developmental approach to understanding risk for PTSD and how pharmacological modulation of acute memories may buffer the development of PTSD symptoms.
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Introduction
Over the past decade, advances in our understanding of the biology of posttraumatic stress disorder (PTSD) have supported the examination of pharmacological approaches initiated soon after trauma exposure in order to reduce or eliminate the development of PTSD in recently traumatized individuals. These so-called secondary intervention approaches have largely been conceptualized and designed from the premise that modulation of stress hormones and the consequent formation of trauma memories could protect against the development of PTSD symptoms. However, inconsistencies abound in these literatures, with perhaps the largest concerning observed differences in findings of studies examining child versus adult trauma victims, necessitating the conceptualization of traumatic stress and early intervention approaches from a developmental perspective. Prior to reviewing the evidence for the initial efficacy and promise of early pharmacologic interventions to prevent/buffer the development of PTSD, the present review will provide a brief historical overview of the role of stress hormones in emotional memory formation with a focus on how altered stress hormone levels can result in aberrant memory formation/PTSD in adults and children. We will then review findings of studies testing early secondary pharmacologic approaches and conclude with a discussion of limitations and important moderators/confounds that need to be considered in future research.
The role of stress hormones in emotional memory formation
Emotionally arousing events are more likely to be remembered than trivial events due to the facilitating influence of stress hormones (McGaugh, 2003) . Emotional arousal and the accompanying release of stress hormones from the sympathetic nervous system (SNS) (i.e., epinephrine and norepinephrine) and the hypothalamic pituitary adrenal (HPA) axis (i.e., glucocorticoids) appear to be important factors in the consolidation and retention of memories for emotionally arousing events.
The role of the SNS in emotional memory
Following stressor onset, the SNS responds with the rapid release of epinephrine and norepinephrine (Sapolsky, Romero, & 
